Effekt selektiver und nicht selektiver nichtsteroidaler Antiphlogistika ...

Literaturverzeichnis
SHUSTER, R., J. TRAUB-DARGATZ u. G. BAXTER (1997):
Survey of diplomates of the American College of Veterinary Internal Medicine and the
American College of Veterinary Surgeons regarding clinical aspects and treatment of
endotoxemia in horses.
J. Am. Vet. Med. Assoc. 210, 87 - 92
SEMRAD, S. D., HARDEE G. E., M. M. HARDEE u. J. N. MOORE (1987):
Low dose Flunixin meglumine: Effects on eicosanoid production and clinical signs
induced by experimental endotoxaemia in horses.
Equine Vet. J. 19, 201 - 206
SNYDER, J. R., H. J. OLANDER, J. R. PASCOE, M. HOLLAND u. C. J.
KURPERSHOEK (1988):
Morphologic alterations observed during experimental ischemia of the equine large
colon.
Am. J. Vet. Res. 49, 801 - 809
SNYDER, J.R. (1989):
The pathophysiology of intestinal damage: effects of luminal distention und ischemia.
Vet. Clin. North Am. Equine Pract. 5, 247 - 270
SOMA, L. R., E. BEHREND, J. RUDY u. R. W. SWEENEY (1988):
Disposition and excretion of flunixin meglumine in horses.
Am. J. Vet. Res. 49, 1984 - 1988
SØRENSEN, O., u. N. BORREGAARD (1999):
Methods for quantitation of human neutrophil proteins, a survey.
J. Immunol. Methods 232, 179 - 190
SOSLOW, R. A., A. J. DANNENBERG, D. RUSH, B. M. WOERNER, K. N. KHAN, J.
MASFERRER u. A. T. KOKI (2000):
COX-2 is expressed in human pulmonary, colonic, and mammary tumors.
Cancer 89, 2637 - 2645
STANTON, M. E., u. BRIGHT R. M. (1989):
Gastroduodenal ulceration in dogs.
J. Vet. Int. Med. 3, 238 - 244
STEAGALL, P. V. M., F. B. MANTOVANI, T. H. FERREIRA, E. S. SALCEDO, F. Q.
MOUTINHO u. S. P. L. LUNA (2007):
Evaluation of the adverse effects of oral firocoxib in healthy dogs.
J. Vet. Pharmacol. Ther. 30, 218 - 223
STRAUMANN, A., u. H.-U. SIMON (2004):
The physiological and pathophysiological roles of eosinophils in the gastrointestinal
tract.
Allergy 59, 15 - 25
198